July 23, 2013
/PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company" or "Alere"), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information solutions, announced that it has filed with the U.S. Securities and Exchange Commission ("SEC") a presentation that was made to Institutional Shareholder Services ("ISS") on
July 22, 2013
Alere is urging stockholders to vote
the election of Alere's new, independent director nominees on the
proxy card at the Company's 2013 Annual Meeting of Stockholders, to be held on
August 7, 2013
The presentation to ISS is available at the SEC's website and can also be viewed by visiting
The presentation outlines the following points:
- Alere's new strategy, which is focused on driving organic revenue growth, operational improvements and cost reductions and deleveraging via cash flow and divestitures of non-core assets, is already unlocking stockholder value.
- The Alere Board's four new, independent director nominees will bring independent thinking, fresh perspectives and significant public company board and CEO experience to the Board of Directors.
- Coppersmith's nominees lack experience relevant to Alere's long-term strategy. Notably, two of its three nominees have never served on the board of directors of a public company.
Alere stockholders are reminded that their vote is important, no matter how many or how few shares they own. Whether or not stockholders plan to attend the Annual Meeting, they have an opportunity to protect their investment in Alere by voting
Alere's director nominees using the
If stockholders have any questions, require assistance with voting the WHITE proxy card, or need additional copies of the proxy materials, please contact:
The Proxy Advisory Group, LLC 18 East 41st Street, Suite 2000 New York,
(888) 337-7699 Or (888) 33 PROXY